Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development

被引:14
作者
Saeidnia, Soodabeh [1 ]
Gohari, Ahmad R. [1 ]
Manayi, Azadeh [1 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Med Plants Res Ctr, Tehran 1417614411, Iran
关键词
Drug discovery; in silico; natural products; reverse pharmacognosy; reverse pharmacology; traditional medicine; NATURAL-PRODUCTS; PERSPECTIVES; STRATEGIES; INHIBITORS; PLANTS;
D O I
10.2174/1389201017666160709200208
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacognosy is a science, which study natural products as a source of new drug leads and effective drug development. Rational and economic search for novel lead structures could maximize the speed of drug discovery by using powerful high technology methods. Reverse pharmacognosy, a complementary to pharmacognosy, couples the high throughput screening (HTS), virtual screening and databases along with the knowledge of traditional medicines. These strategies lead to identification of numerous in vitro active and selective hits enhancing the speed of drug discovery from natural sources. Besides, reverse pharmacology is a target base drug discovery approach; in the first step, a hypothesis is made that the alteration of specific protein activity will produce beneficial curative effects. Both, reverse pharmacognosy and reverse pharmacology take advantages of high technology methods to accomplish their particular purposes. Moreover, reverse pharmacognosy effectively utilize traditional medicines and natural products as promising sources to provide new drug leads as well as promote the rational use of them by using valuable information like protein structure databases and chemical libraries which prepare pharmacological profile of traditional medicine, plant extract or natural compounds.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 42 条
[1]   NATURAL PRODUCT DRUG DISCOVERY AND DEVELOPMENT - NEW PERSPECTIVES ON INTERNATIONAL COLLABORATION [J].
BAKER, JT ;
BORRIS, RP ;
CARTE, B ;
CORDELL, GA ;
SOEJARTO, DD ;
CRAGG, GM ;
GUPTA, MP ;
IWU, MM ;
MADULID, DR ;
TYLER, VE .
JOURNAL OF NATURAL PRODUCTS, 1995, 58 (09) :1325-1357
[2]   Drug discovery from medicinal plants [J].
Balunas, MJ ;
Kinghorn, AD .
LIFE SCIENCES, 2005, 78 (05) :431-441
[3]   Challenges and opportunities confronting the botanical dietary supplement industry [J].
Cardellina, JH .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (07) :1073-1084
[4]   Identification of Escherichia coli enterotoxin inhibitors from traditional medicinal herbs by in silico, in vitro, and in vivo analyses [J].
Chen, Jaw-Chyun ;
Ho, Tin-Yun ;
Chang, Yuan-Shiun ;
Wu, Shih-Lu ;
Li, Chia-Cheng ;
Hsiang, Chien-Yun .
JOURNAL OF ETHNOPHARMACOLOGY, 2009, 121 (03) :372-378
[5]   Lessons from natural molecules [J].
Clardy, J ;
Walsh, C .
NATURE, 2004, 432 (7019) :829-837
[6]  
Do Q., 2006, REVERSE PHARMACOGNOS
[7]   Reverse pharmacognosy:: Identifying biological 3 properties for plants by means of their molecule constituents:: Application to meranzin [J].
Do, Quoc-Tuan ;
Lamy, Cecile ;
Renimel, Isabelle ;
Sauvan, Nancy ;
Andre, Patrice ;
Himbert, Franck ;
Morin-Allory, Luc ;
Bernard, Philippe .
PLANTA MEDICA, 2007, 73 (12) :1235-1240
[8]   Virtual screening of Chinese herbs with random forest [J].
Ehrman, Thomas M. ;
Barlow, David J. ;
Hylands, Peter J. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :264-278
[9]   In silico search for multi-target anti-inflammatories in Chinese herbs and formulas [J].
Ehrman, Thomas M. ;
Barlow, David J. ;
Hylands, Peter J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (06) :2204-2218
[10]  
Filmore D.E.A, 2004, MOD DRUG DISCOV, P8